Home > Inhibitors & Agonists > Tyrosine Kinase > Insulin Receptor
Cat. No. Product name CAS No.
DC5037 BMS-536924 Featured

BMS-536924 is an ATP-competitive IGF-1R inhibitor with IC50 of 100 nM, modest activity for Mek, Fak, and Lck with very little activity for Akt1, MAPK1/2.

468740-43-4
DC8482 CAY10415(MSDC-0160) Featured

CAY10415 is a potent, antidiabetic drug of the TZD structural class.

146062-49-9
DC9754 NT-157 Featured

NT157 is a selective inhibitor of IRS-1/2, IC50 values at sub-micromolar doses (ranging from 0.3 to 0.8 μM) .

1384426-12-3
DC41861 S961 acetate

S961 acetate is an high-affinity and selective insulin receptor (IR) antagonist with IC50s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.

DC42043 GIP (1-30) amide, porcine

GIP (1-30) amide, porcine is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42).

134846-93-8
DC42044 GIP (3-42), human

GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo.

1802086-25-4
DC44220 GIP, human TFA

GIP, human TFA is thought to act as an inhibitor of gastric functions. GIP, human TFA, a peptide hormone consisting of 42 amino acids, is a weak inhibitor of gastric acid secretion and a potent stimulator of insulin post meals.

DC44221 GIP (1-30) amide, porcine TFA

GIP (1-30) amide, porcine TFA is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42). GIP (1-30) amide, porcine is a weak inhibitor of gastric acid secretion and potent stimulator of insulin.

DC45692 DA-JC4

DA-JC4 is a dual GLP-1/GIP receptor agonist can be used for the research of neurological disease and insulin signaling pathways.

2315504-40-4
DC47979 HNMPA

HNMPA is a membrane impermeable insulin receptor tyrosine kinase inhibitor. HNMPA inhibits serine and tyrosine autophosphorylation by the human insulin receptor. HNMPA has no effect on protein kinase C or cyclic AMP-dependent protein kinase activities

132541-52-7
DC48362 OI338

OI338 is an orally available, ultralong-acting insulin analogue.

DC49413 Insulin glargine

Insulin glargine is a long-acting insulin analog. Insulin glargine can be used for the diabetes mellitus.

160337-95-1
DC50118 HNMPA-(AM)3

HNMPA-(AM)3 is a cell-permeable and selective insulin receptor tyrosine kinase inhibitor analog of HNMPA. HNMPA-(AM)3 greatly inhibits the ability of prothoracicotropic hormone (PTTH) to activate ERK phosphorylation and stimulate ecdysteroidogenesis.

120944-03-8
DC50119 AVJ16

AVJ16 is a member of the insulin-like growth factor 2 mRNA-binding protein family. AVJ16 regulates protein translation by binding to the mRNAs of certain genes.

Page 1 / Total 1 FirstPrevNextLastGoto